Shoebill Health Care

Diabetes & Weight Management

Effective diabetes and weight management requires a personalised approach based on your medical condition, lifestyle and health goals. Existing chronic disease subsidised programma clients can follow up with doctor according to their care plan; For others, doctor consultation and relevant health screening are required before starting any treatment plan.
weight management articles sharing blog post

Participation Notice

Medications must be prescribed by doctor and used under the supervision. Individual results and weight loss outcomes may vary. For optimal and sustainable results, treatment must be combined with appropriate lifestyle modifications to help reduce the risk of weight regain.

  • Regular exercise and resistance training
  • Adequate protein intake
  • Balanced nutrition and healthy eating habits

Terms & Conditions

  1. Service items are generally valid for 3 months from the date of purchase unless otherwise specified.
  2. Prescribed medications and purchased items are intended for the registered client’s treatment use and are therefore not transferable or exchangeable. If a client is assessed by the doctor as unsuitable to continue the programme due to medical reasons:
  • Up to 2/3 of the programme fee may be refunded if discontinuation occurs within the first month.
  • Up to 1/3 of the programme fee may be refunded if discontinuation occurs after the first month.
  1. The refundable amount may be adjusted after deducting the original value of medications dispensed, consultations completed, investigations performed and related administrative costs.

Mounjaro® (Eli Lilly)

2.5mg - 10mg

  • Weekly dose: 2.5mg - 10mg
  • Active ingredient: Tirzepatide
  • Gradually adjusts dose to maintenance dose
  • Approx. $214/day
  • GLP-1 & GIP dual receptor agonist

Ozempic® (Novo Nordisk)

0.25mg - 1mg

  • Active ingredient: Semaglutide
  • Gradually adjusts dose to maintenance dose
  • Approx. $143/day
  • Weekly dose: 0.25mg - 1mg
  • Long-acting GLP-1 receptor agonist

Wegovy® (Novo Nordisk)

1.7mg - 2.4mg

  • Higher-dose GLP-1 receptor agonist
  • Gradually adjusts dose to maintenance dose
  • Active ingredient: Semaglutide
  • Weekly dose: 1.7mg - 2.4mg
  • Approx. $179/day

Diabetes & Weight Management Plan

The programme is structured in 12-week cycles, with continuous support and follow-up provided by our registered healthcare team to help you build healthy and sustainable lifestyle. Services include:

  • Designated blood tests (1 time)
  • Doctor follow-up (1 time)
  • Fatty liver screening (1 time)
  • Nurse consultation & injection (1 time weekly)

Medication Options & Costs

Ozempic® (Novo Nordisk)
$12000 /12-weeks
Wegovy® (Novo Nordisk)
$15000 /12-weeks
Mounjaro® (Eli Lilly)
$18000 /12-weeks